These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2413293)
1. In vivo and in vitro assessment of the cardiovascular effects of 8-(benzylthio)-N6-n-butyl-cyclic AMP. Nakazawa M; Takeda K; Nakagawa Y; Tamatsu H; Matsui K; Nakahara H; Kimura T; Kawada T; Imai S J Cardiovasc Pharmacol; 1985; 7(5):862-8. PubMed ID: 2413293 [TBL] [Abstract][Full Text] [Related]
2. Inotropic and chronotropic effects of N6-substituted derivatives of cyclic AMP as assessed in guinea-pig isolated right atria and papillary muscle. Kawada T; Yoshida Y; Imai S Br J Pharmacol; 1989 Jun; 97(2):371-6. PubMed ID: 2547473 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of BTB-cyclic AMP in anesthetized dogs. Imura K; Ogawa K; Ito T; Satake T Jpn Heart J; 1986 Sep; 27(5):741-7. PubMed ID: 3029452 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
5. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition. Shahid M; Rodger IW Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations. Shahid M; Martorana MG; Cottney JE; Marshall RJ Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938 [TBL] [Abstract][Full Text] [Related]
7. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine. Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action. Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145 [TBL] [Abstract][Full Text] [Related]
9. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle. Yanagisawa T; Endoh M; Taira N Jpn J Pharmacol; 1984 Nov; 36(3):379-88. PubMed ID: 6097725 [TBL] [Abstract][Full Text] [Related]
10. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart. Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
12. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine. Katano Y; Endoh M J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732 [TBL] [Abstract][Full Text] [Related]
13. Mode of cardiotonic action of helenalin, a sesquiterpene lactone, on guinea pig ventricular myocardium. Itoigawa M; Takeya K; Furukawa H; Ito K J Cardiovasc Pharmacol; 1987 Feb; 9(2):193-201. PubMed ID: 2435998 [TBL] [Abstract][Full Text] [Related]
14. Positive inotropic and chronotropic effects of trypsin and some other proteolytic enzymes in the guinea-pig heart. Imai S; Kawada T; Kimura T; Ohta H; Nakazawa M; Yoshida Y Br J Pharmacol; 1987 Sep; 92(1):55-62. PubMed ID: 3311266 [TBL] [Abstract][Full Text] [Related]
15. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs. Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931 [TBL] [Abstract][Full Text] [Related]
16. Positive inotropic and chronotropic effects of 8-substituted derivatives of cyclic AMP and activation of protein kinase A. Kimura T Jpn J Pharmacol; 1991 Sep; 57(1):1-11. PubMed ID: 1666132 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3',5'-phosphate (SQ 80122). Evans DB; Parham CS; Schenck MT; Laffan RJ J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):307-19. PubMed ID: 184129 [TBL] [Abstract][Full Text] [Related]
18. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of enoximone. Dage RC; Kariya T; Hsieh CP; Roebel LE; Cheng HC; Schnettler RA; Grisar JM Am J Cardiol; 1987 Aug; 60(5):10C-14C. PubMed ID: 2956861 [TBL] [Abstract][Full Text] [Related]